BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34277395)

  • 1. Identification and Validation of Hub Genes Associated With Hepatocellular Carcinoma
    Wang S; Song Z; Tan B; Zhang J; Zhang J; Liu S
    Front Oncol; 2021; 11():614531. PubMed ID: 34277395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Hub Genes in Liver Hepatocellular Carcinoma Based on Weighted Gene Co-expression Network Analysis.
    Sun J; Zhang Z; Cai J; Li X; Xu X
    Biochem Genet; 2024 Apr; ():. PubMed ID: 38683466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis.
    Qiao Y; Yuan F; Wang X; Hu J; Mao Y; Zhao Z
    Cancer Biomark; 2022; 35(2):227-243. PubMed ID: 36120772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Validation of Hub Genes Associated with Bladder Cancer by Integrated Bioinformatics and Experimental Assays.
    Chen K; Xing J; Yu W; Xia Y; Zhang Y; Cheng F; Rao T
    Front Oncol; 2021; 11():782981. PubMed ID: 34988018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Hub Genes Associated With Development and Microenvironment of Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis and Differential Gene Expression Analysis.
    Bai Q; Liu H; Guo H; Lin H; Song X; Jin Y; Liu Y; Guo H; Liang S; Song R; Wang J; Qu Z; Guo H; Jiang H; Liu L; Yang H
    Front Genet; 2020; 11():615308. PubMed ID: 33414813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.
    Mi N; Cao J; Zhang J; Fu W; Huang C; Gao L; Yue P; Bai B; Lin Y; Meng W; Li X
    Oncol Lett; 2020 Aug; 20(2):1695-1708. PubMed ID: 32724412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Hub Genes Associated With Development of Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis.
    Li CY; Cai JH; Tsai JJP; Wang CCN
    Front Oncol; 2020; 10():681. PubMed ID: 32528874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
    Yang MR; Zhang Y; Wu XX; Chen W
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4248-4256. PubMed ID: 27831650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysis.
    Chi Q; Geng X; Xu K; Wang C; Zhao H
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32537629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
    Li Z; Xu J; Cui H; Song J; Chen J; Wei J
    Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of key modules and hub genes associated with the pathological stage of oral squamous cell carcinoma by weighted gene co-expression network analysis.
    Hu X; Sun G; Shi Z; Ni H; Jiang S
    PeerJ; 2020; 8():e8505. PubMed ID: 32117620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
    Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma.
    Li S; Zhao J; Lv L; Dong D
    Front Oncol; 2021; 11():762821. PubMed ID: 34858842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying novel biomarkers in hepatocellular carcinoma by weighted gene co-expression network analysis.
    Li B; Pu K; Wu X
    J Cell Biochem; 2019 Jul; 120(7):11418-11431. PubMed ID: 30746803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Flap endonuclease 1 as a potential core gene in hepatocellular carcinoma by integrated bioinformatics analysis.
    Li C; Qin F; Hong H; Tang H; Jiang X; Yang S; Mei Z; Zhou D
    PeerJ; 2019; 7():e7619. PubMed ID: 31534853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.